KERAGEL- dressing, wound, drug
MOLECULAR BIOLOGICALS, LLC
----------
keragel® is a keratin enriched gel category dressing utilizing keratin technology to create and maintain a moist wound environment. It is presented sterile in a tube for ease of application.
keragel® is designed for acute/chronic superficial and partial thickness wounds with dry to medium exudate, such as:
If the wound is infected, it is advised that you consult with your physician or health care professional.
The wound should be inspected daily or as indicated by a physician. For wounds that appear dry more gel should be applied to the area. Wounds should be cleansed regularly and new gel applied.
Keratin, phenoxyethanol, hydroxyethylcellulose, glycerol, sorbitol, propylene glycol, lactic acid.
keragel® 20gm individual tube: | NDC 71474-301-20 |
keragel 5 gm individual tube: | NDC 71474-301-05 |
keragel® should be stored in dry conditions between 0° and 35°C (32° and 95° F).
Do not use if the tube has been damaged prior to use. Sterility is guaranteed until the tube is first opened. Do not re-sterilise.
CAUTION: RX ONLY. Federal law restricts this device to sale by or on the order of a physician.
Manufactured for: Molecular Biologicals, LLC
Pasadena, TX 77505 | 1-844-793-9933
EC | REP |
Keraplast Research Limited, Gerald St., Lincoln 7674, NZ
Medical Device Consultancy, 7 Pinewood Drive, Ashley Heath,
Market Drayton, Shropshire TF9 4PA, United Kingdom
keragelT® is a registered trademark of
Keraplast Technologies LLC.
The product incorporates patented and/or patent pending
technologies owned by Keraplast Technologies LLC.
Issue Date 8/2017
DWG106/1
KERAGEL
dressing, wound, drug |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - MOLECULAR BIOLOGICALS, LLC (079518915) |